Fig. 3

Expression signature and prognostic value of TMSB10 in glioma. A The mRNA expression level of TMSB10 increased with tumor grade in the (left) CGGA, (middle) TCGA and (right) Gravendeel datasets. B Kaplan–Meier curves for the OS of (upper) LGG and (lower) GBM patients with high TMSB10 expression and low TMSB10 expression in three glioma datasets; the log-rank test was used to calculate the p value. C ROC curve showing that, among other clinical characteristics, the expression level of TMSB10 had the largest AUC in predicting the survival rate of glioma patients in three glioma datasets. D Univariate and multivariate analyses of TMSB10 expression and clinicopathological characteristics in three glioma datasets